Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 56.79%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 428.92%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -4.24%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -30.53%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 36.88%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 186.74%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 210.36%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 43.45%
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn -122.17%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -122.17%
Dec 31, 2025 -105.57%
Sep 30, 2025 228.74%
Jun 30, 2025 425.65%
Mar 31, 2025 112.83%
Dec 31, 2024 -59.91%
Sep 30, 2024 -119.31%
Jun 30, 2024 -123.82%
Mar 31, 2024 -22.57%
Dec 31, 2023 60.62%
Sep 30, 2023 571.96%
Jun 30, 2023 1,969.47%
Mar 31, 2023 191.24%
Dec 31, 2022 2,189.74%
Sep 30, 2022 198.33%
Jun 30, 2022 -124.74%
Mar 31, 2022 -291.51%
Dec 31, 2021 -95.30%
Sep 30, 2021 -141.33%
Jun 30, 2021 -67.64%
Mar 31, 2021 -63.88%
Dec 31, 2020 12.16%
Sep 30, 2020 -49.43%
Jun 30, 2020 261.19%
Mar 31, 2020 42.84%
Dec 31, 2019 -14.38%
Sep 30, 2019 320.22%
Jun 30, 2019 -48.55%
Mar 31, 2019 348.66%
Dec 31, 2018 376.14%
Sep 30, 2018 -167.29%
Jun 30, 2018 168.84%
Mar 31, 2018 173.44%
Dec 31, 2017 -154.37%
Sep 30, 2017 -38.05%
Jun 30, 2017 -49.58%
Mar 31, 2017 15.98%
Dec 31, 2016 -2.10%
Sep 30, 2016 4,510.26%
Jun 30, 2016 294.63%
Mar 31, 2016 -46.08%
Dec 31, 2015 39.67%
Sep 30, 2015 -112.96%
Jun 30, 2015 -134.23%
Mar 31, 2015 -146.36%
Dec 31, 2014 1.12%
Sep 30, 2014 -57.93%
Jun 30, 2014 75.87%
Mar 31, 2014 86.11%
Dec 31, 2013 -11.17%
Sep 30, 2013 -42.83%
Jun 30, 2013 -68.45%
Mar 31, 2013 -64.11%
Dec 31, 2012 -46.80%
Sep 30, 2012 106.86%
Jun 30, 2012 54.33%
Mar 31, 2012 40.30%
Dec 31, 2011 -37.80%
Sep 30, 2011 -34.67%